Skip to main content
Clinical Trials/CTRI/2022/12/047966
CTRI/2022/12/047966
Recruiting
Phase 3

A comparative study of the therapeutic efficacy of oral clonazepam and oral baclofen on spasms among patients with spinal cord injury: A randomised controlled trial.

Bharat Pulavarti0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: S140- Concussion and edema of cervical spinal cordHealth Condition 2: S340- Concussion and edema of lumbar andsacral spinal cordHealth Condition 3: S240- Concussion and edema of thoracic spinal cordHealth Condition 4: S141- Other and unspecified injuries ofcervical spinal cordHealth Condition 5: S241- Other and unspecified injuries ofthoracic spinal cordHealth Condition 6: S341- Other and unspecified injury of lumbar and sacral spinal cord
Sponsor
Bharat Pulavarti
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Bharat Pulavarti

Eligibility Criteria

Inclusion Criteria

  • Spinal cord injury patients in the above age group, suffering from spasms, have sufficient mental capacity to respond relevantly to all queries related to spasms.

Exclusion Criteria

  • Spinal cord injury patients who exhibit spasticity but do not present with spasms.
  • Patients who are pregnant.
  • Patients with narrow angle glaucoma.
  • Patients with history of clinical depression and suicidal tendencies. Patients who are currently on antispastic and anti\-spasm medication will not be enrolled in the study.
  • Patients with deranged complete blood count, liver function tests and renal function tests.
  • Patients with pre\-existing musculoskeletal disorders and movement disorders in which spasms and spasticity cannot be assessed accurately.

Outcomes

Primary Outcomes

Not specified

Similar Trials